Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:4.1.2.42 (
DTA
)
1,693
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Neoglycoalbumin (NGA), a special ligend of asialoglycoprotein receptor on the hepatocyte, was linked via a butanediacyl bridge to acyclovir to form a conjugate NGA-
ACV
. By using
DTA
(Differential thermoanalysis) and HPLC analysis,
ACV
was shown to be connected with NGA by covalent bonds and stable in blood. The radio-biodistribution of 131I-NGA-
ACV
with high drug density in vivo was carried out in mice. The maximum absorption of 131I-NGA-
ACV
in liver was 81.7 +/- 10.4% at 5 min. The radioimage of 131I-NGA-
ACV
with high or low drug density in rabbit showed no significant difference in liver targeting property. The competitive connection tests indicated that 131I-NGA-
ACV
was concentrated in liver through receptor mediated mechanism. A tentative test of antihepatitis B of NGA-
ACV
and
ACV
in vitro showed that the effective dose of the former was significantly lower than that of the latter.
...
PMID:[Preparation of hepatic targeting antivirus agent NGA-ACV and its targeting property]. 977 5
Although acyclovir is one of the most important antiviral drugs used today, there are several problems with its physical properties. The aim of this study is to prepare cocrystals or amorphous complex of acyclovir using drug-excipient interactions to improve the physical properties of the drug, especially its dissolution rate and transdermal absorption. Screening for formation of cocrystals and the presence of amorphous acyclovir was conducted with various pharmaceutical excipinents, with the use of the solution-crystallization method and liquid-assisted cogrinding. The potential cocrystalline phase and the amorphized complex were characterized by PXRD, TG/
DTA
, IR, DSC and HPLC techniques. The screening indicated that acyclovir formed novel cocrystals with tartaric acid and was amorphized with citric acid. The acyclovir-tartaric acid cocrystal (
ACV
-TA cocrystal) structure was determined from synchrotron X-ray powder diffraction data. T(g) of the amorphous acyclovir-citric acid compound (
ACV
-CA amorphous) was determined by DSC. The initial dissolution rate of the
ACV
-TA cocrystals was considerably faster than that of anhydrous acyclovir. In vitro skin permeation of
ACV
-CA amorphous from polyethylene glycol (PEG) ointment was remarkably higher than that of the crystalline acyclovir. We successfully improved the physical properties of acyclovir by the cocrystallization and amorphization techniques, using pharmaceutical excipients.
...
PMID:Cocrystallization and amorphization induced by drug-excipient interaction improves the physical properties of acyclovir. 2207 14